Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
World Academy of Sciences Journal
Join Editorial Board Propose a Special Issue
Print ISSN: 2632-2900 Online ISSN: 2632-2919
Journal Cover
September-October 2019 Volume 1 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-October 2019 Volume 1 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review)

  • Authors:
    • Shogo Imanaka
    • Haruki Nakamura
    • Hiroshi Kobayashi
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634‑8522, Japan
    Copyright: © Imanaka et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 203-218
    |
    Published online on: October 15, 2019
       https://doi.org/10.3892/wasj.2019.25
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Adenomyosis is one of the most common gynecological diseases worldwide. Despite intense efforts to elucidate the pathogenesis, the molecular mechanisms responsible for adenomyosis are not yet fully understood. The aim of this review was to screen candidate functional networks and identify key genes to differentiate adenomyosis from endometriosis. A search was conducted between 2000 and 2018 through the English language literature (online MEDLINE PubMed database) using the key words, adenomyosis combined with endometriosis, differentially expressed genes (DEGs) and functional networks. Eligible microarray datasets were collected from the NCBI Gene Expression Omnibus (GEO) database, NCBI‑GEO (http://www.ncbi.nlm.nih.gov/geo/). The mRNA and/or protein expression of adenomyosis candidate genes was confirmed by the published data (https://www.ncbi.nlm.nih.gov/pubmed). The comprehensive gene expression analysis based on the NCBI‑GEO database revealed the candidate DEGs and functional networks. Among a total of 3,119 genes collected from the adenomyosis signatures, 2,845 genes (91.2%) overlapped in the endometriosis signatures. A total of 274 DEGs were identified to be specific to adenomyotic lesions. Among these, we selected 50 genes whose expression profiles have been published in a public repository. Although the two conditions may share common pathways, a set of DEGs, including insulin‑like growth factor 1 (IGF1), osteopontin (OPN), KiSS‑1 metastasis suppressor (KISS1), neural cell adhesion molecule 1 (NCAM1, also known as CD56), versican (VCAN), L‑selectin ligand and Annexin A2, (ANXA2), have been suggested to play a pivotal role in the pathophysiology of adenomyosis. The enriched functions and pathways of the DEGs include the process of endometrial invasion, cell survival, wound healing, scarring and fibrosis. On the whole, in this review, we present a comprehensive gene expression analysis based on NCBI‑GEO database to identify adenomyosis candidate genes. DEGs and functional networks help us to understand the molecular mechanisms underlying the pathogenesis of adenomyosis, and provide candidate targets for the diagnosis and treatment of adenomyosis.
View Figures

Figure 1

View References

1 

Harada T, Khine YM, Kaponis A, Nikellis T, Decavalas G and Taniguchi F: The impact of adenomyosis on Women's fertility. Obstet Gynecol Surv. 71:557–568. 2016.PubMed/NCBI View Article : Google Scholar

2 

García-Solares J, Donnez J, Donnez O and Dolmans MM: Pathogenesis of uterine adenomyosis: Invagination or metaplasia? Fertil Steril. 109:371–379. 2018.PubMed/NCBI View Article : Google Scholar

3 

Puente JM, Fabris A, Patel J, Patel A, Cerrillo M, Requena A and Garcia-Velasco JA: Adenomyosis in infertile women: Prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol. 14(60)2016.PubMed/NCBI View Article : Google Scholar

4 

Kishi Y, Suginami H, Kuramori R, Yabuta M, Suginami R and Taniguchi F: Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification. Am J Obstet Gynecol. 207:114.e1–e7. 2012.PubMed/NCBI View Article : Google Scholar

5 

Vercellini P, Viganò P, Somigliana E and Fedele L: Endometriosis: Pathogenesis and treatment. Nat Rev Endocrinol. 10:261–275. 2014.PubMed/NCBI View Article : Google Scholar

6 

Crispi S, Piccolo MT, D'Avino A, Donizetti A, Viceconte R, Spyrou M, Calogero RA, Baldi A and Signorile PG: Transcriptional profiling of endometriosis tissues identifies genes related to organogenesis defects. J Cell Physiol. 228:1927–1934. 2013.PubMed/NCBIPubMed/NCBI View Article : Google Scholar

7 

Abe W, Nasu K, Nakada C, Kawano Y, Moriyama M and Narahara H: miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells. Hum Reprod. 28:750–761. 2013.PubMed/NCBI View Article : Google Scholar

8 

Tamaresis JS, Irwin JC, Goldfien GA, Rabban JT, Burney RO, Nezhat C, DePaolo LV and Giudice LC: Molecular classification of endometriosis and disease stage using high-dimensional genomic data. Endocrinology. 155:4986–4999. 2014.PubMed/NCBI View Article : Google Scholar

9 

Saare M, Modhukur V, Suhorutshenko M, Rajashekar B, Rekker K, Sõritsa D, Karro H, Soplepmann P, Sõritsa A, Lindgren CM, et al: The influence of menstrual cycle and endometriosis on endometrial methylome. Clin Epigenetics. 8(2)2016.PubMed/NCBI View Article : Google Scholar

10 

Zhao L, Gu C, Ye M, Zhang Z, Li L, Fan W and Meng Y: Integration analysis of microRNA and mRNA paired expression profiling identifies deregulated microRNA-transcription factor-gene regulatory networks in ovarian endometriosis. Reprod Biol Endocrinol. 16(4)2018.PubMed/NCBI View Article : Google Scholar

11 

Yamagata Y, Nishino K, Takaki E, Sato S, Maekawa R, Nakai A and Sugino N: Genome-wide DNA methylation profiling in cultured eutopic and ectopic endometrial stromal cells. PLoS One. 9(e83612)2014.PubMed/NCBI View Article : Google Scholar

12 

Zhou C, Zhang T, Liu F, Zhou J, Ni X, Huo R and Shi Z: The differential expression of mRNAs and long noncoding RNAs between ectopic and eutopic endometria provides new insights into adenomyosis. Mol Biosyst. 12:362–370. 2016.PubMed/NCBI View Article : Google Scholar

13 

Herndon CN, Aghajanova L, Balayan S, Erikson D, Barragan F, Goldfien G, Vo KC, Hawkins S and Giudice LC: Global transcriptome abnormalities of the eutopic endometrium from women with adenomyosis. Reprod Sci. 23:1289–1303. 2016.PubMed/NCBI View Article : Google Scholar

14 

Jiang JF, Sun AJ, Xue W, Deng Y and Wang YF: Aberrantly expressed long noncoding RNAs in the eutopic endometria of patients with uterine adenomyosis. Eur J Obstet Gynecol Reprod Biol. 199:32–37. 2016.PubMed/NCBI View Article : Google Scholar

15 

Tang Q, Wang Q, Zhang Q, Lin SY, Zhu Y, Yang X and Guo AY: Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues. BMC Cancer. 17(862)2017.PubMed/NCBI View Article : Google Scholar

16 

Levy M, Mittal K, Chiriboga L, Zhang X, Yee H and Wei JJ: Differential expression of selected gene products in uterine leiomyomata and adenomyosis. Fertil Steril. 88:220–223. 2007. View Article : Google Scholar

17 

Konopka B, Skasko E, Kluska A, Goluda M, Janiec-Jankowska A, Paszko Z and Ujec M: Changes in the concentrations of receptors of insulin-like growth factor-I, epithelial growth factor, oestrogens and progestagens in adenomyosis foci, endometrium and myometrium of women during menstrual cycle. Eur J Gynaecol Oncol. 19:93–97. 1998.PubMed/NCBI

18 

Chang SY and Ho YS: Immunohistochemical analysis of insulin-like growth factor I, insulin-like growth factor I receptor and insulin-like growth factor II in endometriotic tissue and endometrium. Acta Obstet Gynecol Scand. 76:112–117. 1997.PubMed/NCBI View Article : Google Scholar

19 

Kim JG, Suh CS, Kim SH, Choi YM, Moon SY and Lee JY: Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis. Fertil Steril. 73:996–1000. 2000.PubMed/NCBI View Article : Google Scholar

20 

Streuli I, Santulli P, Chouzenoux S, Chapron C and Batteux F: Serum osteopontin levels are decreased in focal adenomyosis. Reprod Sci. 24:773–782. 2017.PubMed/NCBI View Article : Google Scholar

21 

Xiao Y, Li T, Xia E, Yang X, Sun X and Zhou Y: Expression of integrin β3 and osteopontin in the eutopic endometrium of adenomyosis during the implantation window. Eur J Obstet Gynecol Reprod Biol. 170:419–422. 2013.PubMed/NCBI View Article : Google Scholar

22 

Cho S, Ahn YS, Choi YS, Seo SK, Nam A, Kim HY, Kim JH, Park KH, Cho DJ and Lee BS: Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis. Am J Reprod Immunol. 61:286–293. 2009.PubMed/NCBI View Article : Google Scholar

23 

Kolioulis I, Zafrakas M, Grimbizis G, Miliaras D, Timologou A, Bontis JN and Tarlatzis BC: Immunohistochemical expression pattern of metastasis suppressor KISS-1 protein in adenomyosis lesions and normal endometrium. Eur J Obstet Gynecol Reprod Biol. 210:64–68. 2017.PubMed/NCBI View Article : Google Scholar

24 

Ji K, Ye L, Mason MD and Jiang WG: The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (Review). Int J Mol Med. 32:747–754. 2013.PubMed/NCBI View Article : Google Scholar

25 

Timologou A, Zafrakas M, Grimbizis G, Miliaras D, Kotronis K, Stamatopoulos P and Tarlatzis BC: Immunohistochemical expression pattern of metastasis suppressors KAI1 and KISS1 in endometriosis and normal endometrium. Eur J Obstet Gynecol Reprod Biol. 199:110–115. 2016.PubMed/NCBI View Article : Google Scholar

26 

Hussain MA, Song WJ and Wolfe A: There is Kisspeptin- and then there is kisspeptin. Trends Endocrinol Metab. 26:564–572. 2015.PubMed/NCBI View Article : Google Scholar

27 

Fratangelo F, Carriero MV and Motti ML: Controversial role of Kisspeptins/KiSS-1R signaling system in tumor development. Front Endocrinol (Lausanne). 9(192)2018.PubMed/NCBI View Article : Google Scholar

28 

Wang F, Shi X, Qin X, Wen Z, Zhao X and Li C: Expression of CD56 in patients with adenomyosis and its correlation with dysmenorrhea. Eur J Obstet Gynecol Reprod Biol. 194:101–105. 2015.PubMed/NCBI View Article : Google Scholar

29 

Oosterlynck DJ, Meuleman C, Lacquet FA, Waer M and Koninckx PR: Flow cytometry analysis of lymphocyte subpopulations in peritoneal fluid of women with endometriosis. Am J Reprod Immunol. 31:25–31. 1994.PubMed/NCBI View Article : Google Scholar

30 

Tani H, Sato Y, Ueda M, Miyazaki Y, Suginami K, Horie A, Konishi I and Shinomura T: Role of Versican in the pathogenesis of peritoneal endometriosis. J Clin Endocrinol Metab. 101:4349–4356. 2016.PubMed/NCBI View Article : Google Scholar

31 

Lai TH, Chang FW, Lin JJ and Ling QD: Endometrial L-selectin ligand is downregulated in the mid-secretory phase during the menstrual cycle in women with adenomyosis. Taiwan J Obstet Gynecol. 57:507–516. 2018.PubMed/NCBI View Article : Google Scholar

32 

Zhou S, Yi T, Liu R, Bian C, Qi X, He X, Wang K, Li J, Zhao X, Huang C and Wei Y: Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis. Mol Cell Proteomics. 11(M112.017988)2012.PubMed/NCBI View Article : Google Scholar

33 

Wu MH, Chuang PC, Lin YJ and Tsai SJ: Suppression of annexin A2 by prostaglandin E2 impairs phagocytic ability of peritoneal macrophages in women with endometriosis. Hum Reprod. 28:1045–1053. 2013.PubMed/NCBI View Article : Google Scholar

34 

Fowler PA, Tattum J, Bhattacharya S, Klonisch T, Hombach-Klonisch S, Gazvani R, Lea RG, Miller I, Simpson WG and Cash P: An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: A heterogeneous tissue with a complex disease. Proteomics. 7:130–142. 2007.PubMed/NCBI View Article : Google Scholar

35 

Chen CY, Lin YS, Chen CH and Chen YJ: Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma. J Biomed Sci. 25(30)2018.PubMed/NCBI View Article : Google Scholar

36 

Yang JH, Wu MY, Chen CD, Chen MJ, Yang YS and Ho HN: Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum Reprod. 22:945–952. 2007.PubMed/NCBI View Article : Google Scholar

37 

Matsumoto Y, Iwasaka T, Yamasaki F and Sugimori H: Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol. 94:71–77. 1999.PubMed/NCBI View Article : Google Scholar

38 

Jones RK, Searle RF and Bulmer JN: Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum Reprod. 13:3496–3502. 1998.PubMed/NCBI View Article : Google Scholar

39 

Hu H, Li H and He Y: MicroRNA-17 downregulates expression of the PTEN gene to promote the occurrence and development of adenomyosis. Exp Ther Med. 14:3805–3811. 2017.PubMed/NCBI View Article : Google Scholar

40 

Lai TH, Wu PH and Wu WB: Involvement of NADPH oxidase and NF-κB activation in CXCL1 induction by vascular endothelial growth factor in human endometrial epithelial cells of patients with adenomyosis. J Reprod Immunol. 118:61–69. 2016.PubMed/NCBI View Article : Google Scholar

41 

Goteri G, Lucarini G, Montik N, Zizzi A, Stramazzotti D, Fabris G, Tranquilli AL and Ciavattini A: Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1alpha (HIF-1alpha), and microvessel density in endometrial tissue in women with adenomyosis. Int J Gynecol Pathol. 28:157–163. 2009.PubMed/NCBI View Article : Google Scholar

42 

Huang TS, Chen YJ, Chou TY, Chen CY, Li HY, Huang BS, Tsai HW, Lan HY, Chang CH, Twu NF, et al: Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells. J Cell Mol Med. 18:1358–1371. 2014.PubMed/NCBI View Article : Google Scholar

43 

Khan KN, Kitajima M, Hiraki K, Fujishita A, Nakashima M and Masuzaki H: Involvement of hepatocyte growth factor-induced epithelial-mesenchymal transition in human adenomyosis. Biol Reprod. 92(35)2015.PubMed/NCBI View Article : Google Scholar

44 

Yerlikaya G, Balendran S, Pröstling K, Reischer T, Birner P, Wenzl R, Kuessel L, Streubel B and Husslein H: Comprehensive study of angiogenic factors in women with endometriosis compared to women without endometriosis. Eur J Obstet Gynecol Reprod Biol. 204:88–98. 2016.PubMed/NCBI View Article : Google Scholar

45 

Fukaya T, Sugawara J, Yoshida H, Murakami T and Yajima A: Intercellular adhesion molecule-1 and hepatocyte growth factor in human endometriosis: Original investigation and a review of literature. Gynecol Obstet Invest. 47 (Suppl 1):S11–S17. 1999.PubMed/NCBI View Article : Google Scholar

46 

Carrarelli P, Yen CF, Funghi L, Arcuri F, Tosti C, Bifulco G, Luddi A, Lee CL and Petraglia F: Expression of inflammatory and neurogenic mediators in adenomyosis. Reprod Sci. 24:369–375. 2017.PubMed/NCBI View Article : Google Scholar

47 

Li Y, Zou S, Xia X and Zhang S: Human adenomyosis endometrium stromal cells secreting more nerve growth factor: Impact and effect. Reprod Sci. 22:1073–1082. 2015.PubMed/NCBI View Article : Google Scholar

48 

Kajitani T, Maruyama T, Asada H, Uchida H, Oda H, Uchida S, Miyazaki K, Arase T, Ono M and Yoshimura Y: Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis. Endocr J. 60:1155–1164. 2013.PubMed/NCBI View Article : Google Scholar

49 

Lee SR, Kim SH, Lee YJ, Hong SH, Chae HD, Kim CH, Kang BM and Choi YM: Expression of epidermal growth factor, fibroblast growth factor-2, and platelet-derived growth factor-A in the eutopic endometrium of women with endometriosis. J Obstet Gynaecol Res. 33:242–247. 2007.PubMed/NCBI View Article : Google Scholar

50 

Yang RQ, Teng H, Xu XH, Liu SY, Wang YH, Guo FJ and Liu XJ: Microarray analysis of microRNA deregulation and angiogenesis-related proteins in endometriosis. Genet Mol Res. Jun 3, 2016 (Epub ahead of print). doi: 10.4238/gmr.15027826. View Article : Google Scholar

51 

Propst AM, Quade BJ, Gargiulo AR, Nowak RA and Stewart EA: Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium. Menopause. 8:368–371. 2001.PubMed/NCBI View Article : Google Scholar

52 

Guo Q, Zhang H, Zhao X, Fu Y, Zhang J and Li M: Loss of expressions of Dusp6, Sprouty4, and Sef, negative regulators of FGF2/ERK1/2 signaling, in the endometrium of women with adenomyosis. Int J Gynecol Pathol. 33:288–297. 2014.PubMed/NCBI View Article : Google Scholar

53 

Streuli I, Santulli P, Chouzenoux S, Chapron C and Batteux F: Activation of the MAPK/ERK cell-signaling pathway in uterine smooth muscle cells of women with Adenomyosis. Reprod Sci. 22:1549–1560. 2015.PubMed/NCBI View Article : Google Scholar

54 

Guo J, Gao J, Yu X, Luo H, Xiong X and Huang O: Expression of DJ-1 and mTOR in eutopic and ectopic endometria of patients with endometriosis and adenomyosis. Gynecol Obstet Invest. 79:195–200. 2015.PubMed/NCBI View Article : Google Scholar

55 

Goumenou A, Panayiotides I, Matalliotakis I, Vlachonikolis I, Tzardi M and Koumantakis E: Bcl-2 and Bax expression in human endometriotic and adenomyotic tissues. Eur J Obstet Gynecol Reprod Biol. 99:256–260. 2001.PubMed/NCBI View Article : Google Scholar

56 

Preya UH, Woo JH, Choi YS and Choi JH: HNF1β protects endometriotic cells against apoptotic cell death by upregulating the expression of anti-apoptotic genes. Biol Reprod. Jun 18, 2019 (Epub ahead of print). doi: 10.1093/biolre/ioz127. PubMed/NCBI View Article : Google Scholar

57 

Li J, Yanyan M, Mu L, Chen X and Zheng W: The expression of Bcl-2 in adenomyosis and its effect on proliferation, migration, and apoptosis of endometrial stromal cells. Pathol Res Pract. 215(152477)2019.PubMed/NCBI View Article : Google Scholar

58 

Ren Y, Mu L, Ding X and Zheng W: Decreased expression of Beclin 1 in eutopic endometrium of women with adenomyosis. Arch Gynecol Obstet. 282:401–406. 2010.PubMed/NCBI View Article : Google Scholar

59 

Zhang L, Liu Y, Xu Y, Wu H, Wei Z and Cao Y: The expression of the autophagy gene beclin-1 mRNA and protein in ectopic and eutopic endometrium of patients with endometriosis. Int J Fertil Steril. 8:429–436. 2015.PubMed/NCBI View Article : Google Scholar

60 

Liu Y, Tan X, Wang Z, Li Y, Gao M, Li Y, Fang Z, Sun Y, Zhang L, Wang X and Wei Z: Down-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients. Curr Res Transl Med. 64:123–128. 2016.PubMed/NCBI View Article : Google Scholar

61 

Li Y, Wang X, Wang X, Wan L, Liu Y, Shi Y, Zhang L, Fang Z and Wei Z: PDCD4 suppresses proliferation, migration, and invasion of endometrial cells by inhibiting autophagy and NF-κB/MMP2/MMP9 signal pathway. Biol Reprod. 99:360–372. 2018.PubMed/NCBI View Article : Google Scholar

62 

Maia H Jr, Maltez A, Studart E, Athayde C and Coutinho EM: Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis. Gynecol Endocrinol. 20:127–131. 2005.PubMed/NCBI View Article : Google Scholar

63 

Thiruchelvam U, Wingfield M and O'Farrelly C: Natural killer cells: Key players in endometriosis. Am J Reprod Immunol. 74:291–301. 2015.PubMed/NCBI View Article : Google Scholar

64 

Yang JH, Chen MJ, Chen HF, Lee TH, Ho HN and Yang YS: Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum Reprod. 19:1974–1978. 2004.PubMed/NCBI View Article : Google Scholar

65 

Monsanto SP, Edwards AK, Zhou J, Nagarkatti P, Nagarkatti M, Young SL, Lessey BA and Tayade C: Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients. Fertil Steril. 105:968–977.e5. 2016.PubMed/NCBI View Article : Google Scholar

66 

Propst AM, Quade BJ, Nowak RA and Stewart EA: Granulocyte macrophage colony-stimulating factor in adenomyosis and autologous endometrium. J Soc Gynecol Investig. 9:93–97. 2002.PubMed/NCBI View Article : Google Scholar

67 

Nie J, Lu Y, Liu X and Guo SW: Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis. Fertil Steril. 92:886–889. 2009.PubMed/NCBI View Article : Google Scholar

68 

Liu X, Shen M, Qi Q, Zhang H and Guo SW: Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis. Hum Reprod. 31:734–749. 2016.PubMed/NCBI View Article : Google Scholar

69 

Shen M, Liu X, Zhang H and Guo SW: Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice. Hum Reprod. 31:355–369. 2016.PubMed/NCBI View Article : Google Scholar

70 

An M, Li D, Yuan M, Li Q, Zhang L and Wang G: Interaction of macrophages and endometrial cells induces epithelial-mesenchymal transition-like processes in adenomyosis. Biol Reprod. 96:46–57. 2017.PubMed/NCBI View Article : Google Scholar

71 

Young VJ, Ahmad SF, Duncan WC and Horne AW: The role of TGF-β in the pathophysiology of peritoneal endometriosis. Hum Reprod Update. 23:548–559. 2017.PubMed/NCBI View Article : Google Scholar

72 

Yen CF, Liao SK, Huang SJ, Tabak S, Arcuri F, Lee CL, Arici A, Petraglia F, Wang HS and Kayisli UA: Decreased endometrial expression of leukemia inhibitory factor receptor disrupts the STAT3 signaling in adenomyosis during the implantation window. Reprod Sci. 24:1176–1186. 2017.PubMed/NCBI View Article : Google Scholar

73 

Dimitriadis E, Stoikos C, Stafford-Bell M, Clark I, Paiva P, Kovacs G and Salamonsen LA: Interleukin-11, IL-11 receptoralpha and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window. J Reprod Immunol. 69:53–64. 2006.PubMed/NCBI View Article : Google Scholar

74 

Jiang C, Liu C, Guo J, Chen L, Luo N, Qu X, Yang W, Ren Q and Cheng Z: The Expression of Toll-like receptors in eutopic and ectopic endometrium and its implication in the inflammatory pathogenesis of adenomyosis. Sci Rep. 7(7365)2017.PubMed/NCBI View Article : Google Scholar

75 

Khan KN, Kitajima M, Fujishita A, Nakashima M and Masuzaki H: Toll-like receptor system and endometriosis. J Obstet Gynaecol Res. 39:1281–1292. 2013.PubMed/NCBI View Article : Google Scholar

76 

Sikora J, Mielczarek-Palacz A and Kondera-Anasz Z: Association of the precursor of interleukin-1β and peritoneal inflammation-role in pathogenesis of endometriosis. J Clin Lab Anal. 30:831–837. 2016.PubMed/NCBI View Article : Google Scholar

77 

Wang J, Huang C, Jiang R, Du Y, Zhou J, Jiang Y, Yan Q, Xing J, Hou X, Zhou J, et al: Decreased endometrial IL-10 impairs endometrial receptivity by downregulating HOXA10 expression in women with adenomyosis. Biomed Res Int. 2018(2549789)2018.PubMed/NCBI View Article : Google Scholar

78 

Wang F, Li H, Yang Z, Du X, Cui M and Wen Z: Expression of interleukin-10 in patients with adenomyosis. Fertil Steril. 91:1681–1685. 2009.PubMed/NCBI View Article : Google Scholar

79 

Szamatowicz J, Laudański P, Tomaszewska I and Szamatowicz M: Chemokine growth-regulated-alpha: A possible role in the pathogenesis of endometriosis. Gynecol Endocrinol. 16:137–141. 2002.PubMed/NCBI

80 

Takamura M, Osuga Y, Izumi G, Yoshino O, Koga K, Saito A, Hirata T, Hirota Y, Harada M, Hasegawa A and Taketani Y: Interleukin-17A is present in neutrophils in endometrioma and stimulates the secretion of growth-regulated oncogene-α (Gro-α) from endometrioma stromal cells. Fertil Steril. 98:1218–1224.e1-e2. 2012.PubMed/NCBI View Article : Google Scholar

81 

Yu X, Ren H, Liu T, Yong M and Zhong H: Expression and significance of ERβ and TrkB in endometriosis. Clin Exp Obstet Gynecol. 43:75–81. 2016.PubMed/NCBI

82 

Huang Y, Zheng W, Mu L, Ren Y, Chen X and Liu F: Expression of tyrosine kinase receptor B in eutopic endometrium of women with adenomyosis. Arch Gynecol Obstet. 283:775–780. 2011.PubMed/NCBI View Article : Google Scholar

83 

Tokyol C, Aktepe F, Dilek FH, Sahin O and Arioz DT: Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Pathol. 28:148–156. 2009.PubMed/NCBI View Article : Google Scholar

84 

Chen YJ, Li HY, Chang YL, Yuan CC, Tai LK, Lu KH, Chang CM and Chiou SH: Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors. Fertil Steril. 94:1972–1979.e1-e4. 2010.PubMed/NCBI View Article : Google Scholar

85 

Fagotti A, Ferrandina G, Fanfani F, Legge F, Lauriola L, Gessi M, Castelli P, Barbieri F, Minelli L and Scambia G: Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters. Hum Reprod. 19:393–397. 2004.PubMed/NCBI View Article : Google Scholar

86 

Huang F, Cao J, Liu Q, Zou Y, Li H and Yin T: MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitro. Int J Clin Exp Pathol. 6:2129–2136. 2013.PubMed/NCBI

87 

Li T, Li YG and Pu DM: Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest. 62:229–235. 2006.

88 

Szymanowski K, Mikołajczyk M, Wirstlein P and Dera-Szymanowska A: Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis. Ann Agric Environ Med. 23:649–653. 2016.PubMed/NCBI View Article : Google Scholar

89 

Shan K, Lian-Fu Z, Hui D, Wei G, Na W, Xia J and Yan L: Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China. Mol Hum Reprod. 12:35–39. 2006.PubMed/NCBI View Article : Google Scholar

90 

Ohara R, Michikami H, Nakamura Y, Sakata A, Sakashita S, Satomi K, Shiba-Ishii A, Kano J, Yoshikawa H and Noguchi M: Moesin overexpression is a unique biomarker of adenomyosis. Pathol Int. 64:115–122. 2014.PubMed/NCBI View Article : Google Scholar

91 

Ametzazurra A, Matorras R, García-Velasco JA, Prieto B, Simón L, Martínez A and Nagore D: Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis. Hum Reprod. 24:954–965. 2009.PubMed/NCBI View Article : Google Scholar

92 

Zheng D, Duan H, Wang S, Xu Q, Gan L, Li J and Dong Q: FAK regulates epithelial-mesenchymal transition in adenomyosis. Mol Med Rep. 18:5461–5472. 2018.PubMed/NCBI View Article : Google Scholar

93 

Mu L, Zheng W, Wang L, Chen XJ, Zhang X and Yang JH: Alteration of focal adhesion kinase expression in eutopic endometrium of women with endometriosis. Fertil Steril. 89:529–537. 2008.PubMed/NCBI View Article : Google Scholar

94 

Ruiz LA, Báez-Vega PM, Ruiz A, Peterse DP, Monteiro JB, Bracero N, Beauchamp P, Fazleabas AT and Flores I: Dysregulation of Lysyl oxidase expression in lesions and endometrium of women with endometriosis. Reprod Sci. 22:1496–1508. 2015.PubMed/NCBI View Article : Google Scholar

95 

Zhang D, Li Y, Tian J, Zhang H and Wang S: MiR-202 promotes endometriosis by regulating SOX6 expression. Int J Clin Exp Med. 8:17757–1764. 2015.PubMed/NCBI

96 

Shen F, Liu X, Geng JG and Guo SW: Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: A likely constituent biomarker for recurrence. Am J Pathol. 175:479–488. 2009.PubMed/NCBI View Article : Google Scholar

97 

Nie J, Liu X, Zheng Y, Geng JG and Guo SW: Increased immunoreactivity to SLIT/ROBO1 and its correlation with severity of dysmenorrhea in adenomyosis. Fertil Steril. 95:1164–1167. 2011. View Article : Google Scholar

98 

Roy R, Dagher A, Butterfield C and Moses MA: ADAM12 is a novel regulator of tumor angiogenesis via STAT3 signaling. Mol Cancer Res. 15:1608–1622. 2017.PubMed/NCBI View Article : Google Scholar

99 

Miller MA, Moss ML, Powell G, Petrovich R, Edwards L, Meyer AS, Griffith LG and Lauffenburger DA: Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain. Sci Rep. 5(15150)2015.PubMed/NCBI View Article : Google Scholar

100 

Koike N, Higashiura Y, Akasaka J, Uekuri C, Ito F and Kobayashi H: Epigenetic dysregulation of endometriosis susceptibility genes (Review). Mol Med Rep. 12:1611–1616. 2015.PubMed/NCBI View Article : Google Scholar

101 

Han SJ, Jung SY, Wu SP, Hawkins SM, Park MJ, Kyo S, Qin J, Lydon JP, Tsai SY, Tsai MJ, et al: Estrogen receptor β modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 163:960–974. 2015.PubMed/NCBI View Article : Google Scholar

102 

Jichan N, Xishi L and Guo SW: Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci. 17:995–1005. 2010.PubMed/NCBI View Article : Google Scholar

103 

Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E, Tokunaga H, Utsunomiya H, Yin P, Luo X, et al: Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med. 28:36–43. 2010.PubMed/NCBI View Article : Google Scholar

104 

Pavone ME, Dyson M, Reirstad S, Pearson E, Ishikawa H, Cheng YH and Bulun SE: Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action. Hum Reprod. 26:2157–2164. 2011.PubMed/NCBI View Article : Google Scholar

105 

Zhang Y, Yu P, Sun F, Li TC, Cheng JM and Duan H: Expression of oxytocin receptors in the uterine junctional zone in women with adenomyosis. Acta Obstet Gynecol Scand. 94:412–418. 2015.PubMed/NCBI View Article : Google Scholar

106 

Mechsner S, Bartley J, Loddenkemper C, Salomon DS, Starzinski-Powitz A and Ebert AD: Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts. Fertil Steril. 83 (Suppl 1):S1220–S1231. 2005.PubMed/NCBI View Article : Google Scholar

107 

Guo SW, Mao X, Ma Q and Liu X: Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. Fertil Steril. 99:231–240. 2013.PubMed/NCBI View Article : Google Scholar

108 

Matsuzaki S and Darcha C: Involvement of the Wnt/β-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS One. 8(e76808)2013.PubMed/NCBI View Article : Google Scholar

109 

Schuliga M, Jaffar J, Berhan A, Langenbach S, Harris T, Waters D, Lee PVS, Grainge C, Westall G, Knight D and Stewart AG: Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity. Am J Physiol Lung Cell Mol Physiol. 312:L772–L782. 2017.PubMed/NCBI View Article : Google Scholar

110 

Kolgelier S, Demir NA, Inkaya AC, Sumer S, Ozcimen S, Demir LS, Pehlivan FS, Arslan M and Arpaci A: Serum levels of Annexin A2 as a candidate biomarker for hepatic fibrosis in patients with chronic hepatitis B. Hepat Mon. 15(e30655)2015.PubMed/NCBI View Article : Google Scholar

111 

Hannigan G, Troussard AA and Dedhar S: Integrin-linked kinase: A cancer therapeutic target unique among its ILK. Nat Rev Cancer. 5:51–63. 2005.PubMed/NCBI View Article : Google Scholar

112 

Zhou W, Peng Z, Zhang C, Liu S and Zhang Y: ILK-induced epithelial-mesenchymal transition promotes the invasive phenotype in adenomyosis. Biochem Biophys Res Commun. 497:950–956. 2018.PubMed/NCBI View Article : Google Scholar

113 

Zheng QM, Chen XY, Bao QF, Yu J and Chen LH: ILK enhances migration and invasion abilities of human endometrial stromal cells by facilitating the epithelial-mesenchymal transition. Gynecol Endocrinol. 34:1091–1096. 2018.PubMed/NCBI View Article : Google Scholar

114 

Oh SJ, Shin JH, Kim TH, Lee HS, Yoo JY, Ahn JY, Broaddus RR, Taketo MM, Lydon JP, Leach RE, et al: β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition. J Pathol. 231:210–222. 2013.PubMed/NCBI View Article : Google Scholar

115 

Chen YJ, Li HY, Huang CH, Twu NF, Yen MS, Wang PH, Chou TY, Liu YN, Chao KC and Yang MH: Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. J Pathol. 222:261–270. 2010.PubMed/NCBI View Article : Google Scholar

116 

Yang YM and Yang WX: Epithelial-to-mesenchymal transition in the development of endometriosis. Oncotarget. 8:41679–41689. 2017.PubMed/NCBI View Article : Google Scholar

117 

Matsuzaki S, Botchorishvili R, Pouly JL and Canis M: Targeting the Wnt/β-catenin pathway in endometriosis: A potentially effective approach for treatment and prevention. Mol Cell Ther. 2(36)2014.PubMed/NCBI View Article : Google Scholar

118 

Gonçalves GA: p27kip1 as a key regulator of endometriosis. Eur J Obstet Gynecol Reprod Biol. 221:1–4. 2018.PubMed/NCBI View Article : Google Scholar

119 

Kozachenko IF, Dzhamalutdinova KM, Faizullina NM and Shchegolev AI: Immunohistochemical parameters of Musashi-1 in nodular and diffuse adenomyosis. Bull Exp Biol Med. 163:506–509. 2017.PubMed/NCBI View Article : Google Scholar

120 

Götte M, Wolf M, Staebler A, Buchweitz O, Kelsch R, Schüring AN and Kiesel L: Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. J Pathol. 215:317–329. 2008.PubMed/NCBI View Article : Google Scholar

121 

Song Y, Xiao L, Fu J, Huang W, Wang Q, Zhang X and Yang S: Increased expression of the pluripotency markers sex-determining region Y-box 2 and Nanog homeobox in ovarian endometriosis. Reprod Biol Endocrinol. 12(42)2014.PubMed/NCBI View Article : Google Scholar

122 

Djokovic D and Calhaz-Jorge C: Angiogenesis as a therapeutic target in endometriosis. Acta Med Port. 27:489–497. 2014.PubMed/NCBI View Article : Google Scholar

123 

Liu H, Zhang Z, Xiong W, Zhang L, Xiong Y, Li N, He H, Du Y and Liu Y: Hypoxia-inducible factor-1α promotes endometrial stromal cells migration and invasion by upregulating autophagy in endometriosis. Reproduction. 153:809–820. 2017.PubMed/NCBI View Article : Google Scholar

124 

Scutiero G, Iannone P, Bernardi G, Bonaccorsi G, Spadaro S, Volta CA, Greco P and Nappi L: Oxidative stress and endometriosis: A systematic review of the literature. Oxid Med Cell Longev. 2017(7265238)2017.PubMed/NCBI View Article : Google Scholar

125 

Ota H, Igarashi S, Kato N and Tanaka T: Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril. 74:313–318. 2000.PubMed/NCBI View Article : Google Scholar

126 

Hsu AL, Townsend PM, Oehninger S and Castora FJ: Endometriosis may be associated with mitochondrial dysfunction in cumulus cells from subjects undergoing in vitro fertilization-intracytoplasmic sperm injection, as reflected by decreased adenosine triphosphate production. Fertil Steril. 103:347–352.e1. 2015.PubMed/NCBI View Article : Google Scholar

127 

Chen C, Zhou Y, Hu C, Wang Y, Yan Z, Li Z and Wu R: Mitochondria and oxidative stress in ovarian endometriosis. Free Radic Biol Med. 136:22–34. 2019.PubMed/NCBI View Article : Google Scholar

128 

Ishikawa M, Nakata T, Yaginuma Y, Nishiwaki K, Goishi K and Saitoh S: Expression of superoxide dismutase (SOD) in adenomyosis. Am J Obstet Gynecol. 169:730–734. 1993. View Article : Google Scholar

129 

Van Voorhis BJ, Huettner PC, Clark MR and Hill JA: Immunohistochemical localization of prostaglandin H synthase in the female reproductive tract and endometriosis. Am J Obstet Gynecol. 163:57–62. 1990.PubMed/NCBI View Article : Google Scholar

130 

Kobayashi H, Uekuri C and Shigetomi H: Towards an understanding of the molecular mechanism of endometriosis: Unbalancing epithelial-stromal genetic conflict. Gynecol Endocrinol. 30:7–15. 2014.PubMed/NCBI View Article : Google Scholar

131 

Kobayashi H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi H: The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol. 25:39–52. 2009.PubMed/NCBI View Article : Google Scholar

132 

Akasaka J, Uekuri C, Shigetomi H, Koike M and Kobayashi H: Hepatocyte nuclear factor (HNF)-1β and its physiological importance in endometriosis. Biomed Rep. 1:13–17. 2013.PubMed/NCBI View Article : Google Scholar

133 

Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M and Rumi LS: Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril. 74:760–766. 2000.PubMed/NCBI View Article : Google Scholar

134 

Benagiano G, Brosens I and Habiba M: Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update. 20:386–402. 2014.PubMed/NCBI View Article : Google Scholar

135 

Xiaoyu L, Weiyuan Z, Ping J, Anxia W and Liane Z: Comparative serum proteomic analysis of adenomyosis using the isobaric tags for relative and absolute quantitation technique. Fertil Steril. 100:505–510. 2013.PubMed/NCBI View Article : Google Scholar

136 

Hever A, Roth RB, Hevezi PA, Lee J, Willhite D, White EC, Marin EM, Herrera R, Acosta HM, Acosta AJ and Zlotnik A: Molecular characterization of human adenomyosis. Mol Hum Reprod. 12:737–748. 2006.PubMed/NCBI View Article : Google Scholar

137 

Kobayashi H, Iwai K, Niiro E, Morioka S and Yamada Y: Fetal programming theory: Implication for the understanding of endometriosis. Hum Immunol. 75:208–217. 2014.PubMed/NCBI View Article : Google Scholar

138 

Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW and Petraglia F: Pathogenesis of adenomyosis: An update on molecular mechanisms. Reprod Biomed Online. 35:592–601. 2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
Copy and paste a formatted citation
Spandidos Publications style
Imanaka S, Nakamura H and Kobayashi H: Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review). World Acad Sci J 1: 203-218, 2019.
APA
Imanaka, S., Nakamura, H., & Kobayashi, H. (2019). Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review). World Academy of Sciences Journal, 1, 203-218. https://doi.org/10.3892/wasj.2019.25
MLA
Imanaka, S., Nakamura, H., Kobayashi, H."Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review)". World Academy of Sciences Journal 1.5 (2019): 203-218.
Chicago
Imanaka, S., Nakamura, H., Kobayashi, H."Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review)". World Academy of Sciences Journal 1, no. 5 (2019): 203-218. https://doi.org/10.3892/wasj.2019.25
Copy and paste a formatted citation
x
Spandidos Publications style
Imanaka S, Nakamura H and Kobayashi H: Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review). World Acad Sci J 1: 203-218, 2019.
APA
Imanaka, S., Nakamura, H., & Kobayashi, H. (2019). Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review). World Academy of Sciences Journal, 1, 203-218. https://doi.org/10.3892/wasj.2019.25
MLA
Imanaka, S., Nakamura, H., Kobayashi, H."Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review)". World Academy of Sciences Journal 1.5 (2019): 203-218.
Chicago
Imanaka, S., Nakamura, H., Kobayashi, H."Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review)". World Academy of Sciences Journal 1, no. 5 (2019): 203-218. https://doi.org/10.3892/wasj.2019.25
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team